Cleared Traditional

K212721 - Genex Bone Graft Substitute

K212721 is the FDA 510(k) clearance for Genex Bone Graft Substitute by Biocomposites, Ltd.. It is a Class 2 Orthopedic device (product code MQV) cleared through the Traditional 510(k) pathway after a 161-day FDA review.

K212721 · Biocomposites, Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2022
Decision
161d
Days
Class 2
Risk

K212721 is an FDA 510(k) clearance for the Genex Bone Graft Substitute. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Biocomposites, Ltd. (Keele, GB). The FDA issued a Cleared decision on February 4, 2022 after a review of 161 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Biocomposites, Ltd. devices

Submission Details

510(k) Number K212721 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 2021
Decision Date February 04, 2022
Days to Decision 161 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d slower than avg
Panel avg: 122d · This submission: 161d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 231
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K212721.
FIBERGRAFT Aeridyan Matrix Bone Graft Substitute
K213803 · Prosidyan, Inc. · Aug 2022
Mg OSTEOINJECT
K221256 · Bone Solutions, Inc. · Jun 2022
MagnetOs Flex Matrix
K213959 · Kuros Biosciences B.V · Apr 2022
Osteorevive
K212991 · Bone Solutions, Inc. · Jan 2022
MagnetOs granules
K213111 · Kuros Biosciences B.V · Jan 2022
PRO-DENSE LoVisc Bone Graft Substitute
K213342 · Wrightmedicaltechnologyinc · Jan 2022